Canada markets closed

China Jo-Jo Drugstores, Inc. (CJJD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.5000-0.1800 (-6.72%)
At close: 04:00PM EDT
2.4900 -0.01 (-0.40%)
After hours: 05:51PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close2.6800
Open2.7700
Bid2.3800 x 200
Ask0.0000 x 0
Day's Range2.2700 - 2.7700
52 Week Range1.9500 - 17.8000
Volume28,181
Avg. Volume72,693
Market Cap5.41M
Beta (5Y Monthly)0.05
PE Ratio (TTM)N/A
EPS (TTM)-4.4000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering

    China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.61 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $2.74

  • PR Newswire

    China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering

    China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 m

  • PR Newswire

    China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

    China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on March 15, 2024, notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement and the mat